Jan. 23, 2019 Updated 
In response to the progress of bioscience in recent years, growing attention has been paid to the materials, named biomaterials, that interact with a living body or its composition elements like proteins or the cells, and so on. Many of such biomaterials were already put to practical use with the high-tech devices as central materials, such as artificial organs, drug delivery system and biosensors. In addition, the research and development of new biomaterials are actively carried out all around the world, e.g the material whose structures and functions are changed responding to external stimuli (Intelligent materials) or those who are guiding the proliferation and differentiation of the cells.
------by Kazunori Kataoka From 'Biomaterial Engineering' (Publisher, Shokabo)

Innovation Center of NanoMedicine (iCONM)
3-25-14 Tono-machi, Kawasaki, Kanagawa, 210-0821 Access Map

Policy Alternatives Research Institute
The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033 Access Map
Interview about Prof. Kazunori Kataoka, Director General of iCONM, was carried on article of btcn asia.
▶ (1/21) Part 1: Nanomedicine in neurodegenerative diseases like Alzheimerfs
▶ (1/28) Part 2: The future of nanomedicine for everybody
Dr. Beob Soo Kim Visiting Research Scientist (The University of Tokyo, Miyata Lab.) has received Poster Award: Polymers Award at the IPC2018. The presentation title is "Vesicular self-assemblies from siRNAs and PEGylated block catiomers (siRNAsomes): Their structural, physicochemical, and biological characteristics" (Coauthers: Kanjiro Miyata, Akihiro Kishimura, Kazunori Kataoka).
Dr. Hyun Jin Kim Visiting Research Scientist (The University of Tokyo, Miyata Lab.) has received Best Poster Award at the 5th COINS Symposium. The presentation title is "Development of Amphiphilic Polymers for Cas9 mRNA Delivery" (Coauthers: Kazunori Kataoka, Kanjiro Miyata).
Prof. Kazunori Kataoka, Director General of iCONM, has been named a 2018 Highly Cited Researcher in Clarivate Analytics (Web of Science) meaning that research ranks among the top 1% most cited works in the corresponding field.
Feature article of "In-body hospitals" which is the core theme of iCONM / COINS was published in Nature.
Following Dr. Kazunori Kataoka's interview article, the efforts of iCONM / COINS, National Cancer Research Center East Hospital, Tokyo Women's Medical University, Braizon Therapeutics and Quantum Science and Technology Research and Development organization are introduced.
▶ (11/15)nature
Nanomedicine in Japan